Department of Medicine, Kidney Center, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
Int Urol Nephrol. 2013 Apr;45(2):469-76. doi: 10.1007/s11255-012-0251-8. Epub 2012 Jul 26.
To the best of our knowledge, no study has compared intermittent steroid pulse therapy, according to Pozzi's regimen, with versus without tonsillectomy.
In this retrospective cohort analysis, we compared clinical findings, histological findings according to the Oxford classification, and complete remission rates (RR), defined in terms of urinary protein excretion (U-Prot <0.3 g/g creatinine) and urinary red blood cell count (U-RBC <5/high-power field), after 1 year of treatment in patients with IgA nephropathy (IgAN), who received tonsillectomy with steroid pulse therapy (TSP group, n = 26) or steroid pulse therapy alone (SP group, n = 15).
The baseline clinical and histological characteristics did not differ between the two groups. The RR for U-Prot analyzed by the Kaplan-Meier method did not differ between the groups (76.9 vs. 53.3 %). However, the RR for U-RBC was significantly higher in the TSP than in the SP group (88.4 vs. 33.3 %, log-rank test; P = 0.0008). The RRs for U-Prot and U-RBC were significantly higher in the TSP group than in the SP group (69.2 vs. 13.3 %, log-rank test; P = 0.0019). Cox's regression analysis showed that combination therapy was associated with higher RR (odds ratio, 12.5; 95 % confidence interval, 2.91-86.7; P = 0.0002).
Tonsillectomy combined with steroid pulse therapy achieved higher RR after 1 year of treatment, compared with steroid pulse monotherapy in patients with IgAN. The long-term effects on renal survival should be analyzed in further studies.
据我们所知,尚无研究比较过波济(Pozzi)方案间歇性类固醇脉冲疗法联合与不联合扁桃体切除术的效果。
在这项回顾性队列分析中,我们比较了接受扁桃体切除术联合类固醇脉冲疗法(TSP 组,n=26)或单纯类固醇脉冲疗法(SP 组,n=15)的 IgA 肾病(IgAN)患者在治疗 1 年后的临床发现、根据牛津分类的组织学发现以及完全缓解率(RR),RR 定义为尿蛋白排泄(U-Prot<0.3g/g 肌酐)和尿红细胞计数(U-RBC<5/高倍视野)。
两组间基线临床和组织学特征无差异。Kaplan-Meier 分析法分析的 U-Prot RR 无差异(76.9% vs. 53.3%)。然而,TSP 组的 U-RBC RR 明显高于 SP 组(88.4% vs. 33.3%,对数秩检验;P=0.0008)。TSP 组的 U-Prot 和 U-RBC RR 均明显高于 SP 组(69.2% vs. 13.3%,对数秩检验;P=0.0019)。Cox 回归分析显示,联合治疗与更高的 RR 相关(优势比,12.5;95%置信区间,2.91-86.7;P=0.0002)。
与单纯类固醇脉冲疗法相比,在 IgAN 患者中,扁桃体切除术联合类固醇脉冲疗法在治疗 1 年后可实现更高的 RR。应在进一步研究中分析对肾脏生存的长期影响。